Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Trump Administration, Industry Want Stark Law Changes To Accommodate ACO Formation

Executive Summary

The US administration and the medical device industry are pushing Congress to create exceptions and waivers to Stark law requirements that prohibit physician self-referrals to radiological clinics or other medical facilities in which they have a financial interest. They say the law inhibits formation of accountable care organizations fostered by the Centers for Medicare and Medicaid Services, and hinders value-based health care.

You may also be interested in...

US HHS Inspector General Asks For Data On Anti-Kickback Law Barriers To Value-Based Care

The US HHS Office of Inspector General on Aug. 27 issued a request for information on ways the department may loosen provisions of the anti-kickback statute – such as restrictions on Accountable Care Organization arrangements – that may be acting as barriers in the pursuit of value-based care.

CMS Asks How To Ease Burdens Of US Physician Self-Referral Law

The US Center for Medicare and Medicaid Services launched a request seeking information from the public on how to reduce burdens of the physician self-referral “Stark Law,” which is intended to prevent physicians from enriching themselves with referrals, but has challenged health-care organizations, particularly those participating in accountable care organizations (ACOs), for several years.

Industry Asks CMS To Allow More Medtech Input, Longer-Term Metrics In Bundled Pay Models

Industry groups told the US Medicare agency it should seek the input of a broader array of stakeholders – including medtech companies – in developing future episode-of-care pay models. They also argued that participation in the programs should be voluntary, and that the pay models should account for patient outcomes longer than 90 days following initial care. The responses came in comments to CMS following its proposal to scale back its joint replacement bundled payments program and eliminate a cardiac-care version.


Latest News
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts